Inclinix Launches Redesigned Performance Enrollment Website

WILMINGTON, N.C., Nov. 2 /PRNewswire/ -- Inclinix, Inc. announces today the
launch of its new website at www.inclinix.com. The updated site is a result of
extensive planning, design and development. Inclinix.com provides visitors
with a clear understanding of the Inclinix Performance Enrollment model
through intuitive navigation, a clean design, and a concise presentation of
the most relevant information in an easy-to-use layout.

Inclinix, Inc. is a contract research organization (CRO) specializing in
enrollment solutions for clinical trials in the pharmaceutical, biotechnology
and medical device industries. Inclinix has been providing global investigator
site selection and patient recruitment, education and retention services since
1999 and has led the industry with a pay-for-performance pricing model.

"We understand that our visitors don't have much time to sort through
complicated websites looking for the information they need," explains
Christopher Sleat, Chief Marketing Officer at Inclinix. "The new inclinix.com
not only showcases the creative design and presentation that Inclinix delivers
to our clients, it also enhances the user experience with a clean and
well-organized navigation system."

For more information visit www.inclinix.com.

About Inclinix
Inclinix, Inc. is a global enrollment contract research organization (CRO)
specializing in customized Phase I - IV clinical trial enrollment solutions.
Inclinix services deliver productive investigative sites and qualified
patients for Sponsors, resulting in successfully completed clinical trials for
the pharmaceutical, biotech and medical device industries. Comprehensive
enrollment solutions include site recruitment, patient recruitment, clinical
and medical marketing communications, patient compliance and education, and
the InSite Screener(TM) and InSite Patient Tracker(TM) for comprehensive
patient qualification and retention. Since 1999, Inclinix (formerly PharmaTech
Solutions, Inc.) has participated in over 400 clinical trials in over 130
indications. Inclinix corporate headquarters is located in Wilmington, North
Carolina with additional offices in Annapolis, Maryland, and Gothenburg,
Sweden.

SOURCE Inclinix, Inc.

Kristin Sacre, Marketing Manager, Inclinix, Inc., +1-910-332-2682 ,
ksacre@inclinix.com